Business / Finance RSS Feed - Business / Finance

Illumina signs initial customer deals for new Global Screening Array

Illumina signs initial customer deals for new Global Screening Array

Illumina, Inc. today announced that it has signed deals with 12 customers for its new Infinium Global Screening Array (GSA). [More]
David Gandy becomes new ambassador for Vitabiotics Wellman

David Gandy becomes new ambassador for Vitabiotics Wellman

Known for his passion for fitness and for the championing of top British brands, David Gandy is the new ambassador for Vitabiotics Wellman. [More]
TxCell, LIED collaborate to develop CAR-Treg-based cellular immunotherapy for bullous pemphigoid

TxCell, LIED collaborate to develop CAR-Treg-based cellular immunotherapy for bullous pemphigoid

TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany. [More]
New £95 million investment in pathology services set to bring major benefits to millions of patients

New £95 million investment in pathology services set to bring major benefits to millions of patients

A new £95 million investment in laboratory testing and diagnostic services at Central Manchester University Hospitals NHS Foundation Trust will make a major impact on the wide range of general and specialist services provided to CMFT patients who come from all over the Greater Manchester region and beyond. [More]
Bifodan announces expansion of global operations

Bifodan announces expansion of global operations

Bifodan, a distinct provider of probiotic solutions for the private label nutritional industry, announces a significant expansion of its global operations. [More]
ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

ProBioGen, a leading specialist for contract development and manufacturing of complex glycoproteins and corresponding technologies, today announced that Thermo Fisher Scientific has licensed its GlymaxX® technology for use in development of allergy diagnostics. [More]
Mazor Robotics signs strategic commercial and investment agreements with Medtronic

Mazor Robotics signs strategic commercial and investment agreements with Medtronic

Mazor Robotics Ltd., a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a two-stage, multi-faceted, commercial agreement for co-promotion, co-development and, upon meeting certain milestones, potential global distribution of certain Mazor products. The second agreement is for an equity investment by Medtronic in Mazor. [More]
CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production. [More]
Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Lightpoint Medical, a clinical-stage medical device company developing advanced imaging technologies for intraoperative cancer detection, announced today that the company has signed an exclusive global license agreement for a molecular imaging technology called Beta Emission Tomography, developed by Professor Harrison Barrett, Regents Professor of Radiology and Optical Science, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging. [More]
Arkin Holdings and Primera Capital lead investment of $13M in BioSight

Arkin Holdings and Primera Capital lead investment of $13M in BioSight

BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML. [More]
Oxford Nanoimaging begins sales of desktop optical microscope

Oxford Nanoimaging begins sales of desktop optical microscope

Oxford Nanoimaging commence sales of an elegant desktop optical microscope capable of zooming in on objects as tiny as structures inside living cells. This super-resolution microscope will allow scientists to watch how individual molecules perform chemical reactions in real-time. [More]
Daiichi buys Japanese rights to CTL’s innovative cardiac regeneration medicine, Heartcel

Daiichi buys Japanese rights to CTL’s innovative cardiac regeneration medicine, Heartcel

Cell Therapy Ltd. today announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcel™ (immuno-modulatory progenitor [iMP] cells) to Daiichi Sankyo. [More]

ITL Virginia successfully completes three years of operation

Monday, 1 May will see ITL celebrate an important milestone, as the company marks three years since launching its US operation, ITL Virginia. [More]
Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Protea Biosciences Group, Inc. announced today that it had entered into an exclusive license agreement with Yale University for new technology to improve the differential diagnosis of malignant melanoma. [More]
METTLER TOLEDO named 'Best Weighing Company' and 'Best Laboratory Scale/Balance' in 2016 Reader’s Choice Awards

METTLER TOLEDO named 'Best Weighing Company' and 'Best Laboratory Scale/Balance' in 2016 Reader’s Choice Awards

Nominated by users, METTLER TOLEDO is proud to announce that it has once again been named “Best Weighing Company” and “Best Laboratory Scale/Balance” in the Weighing Review Reader’s Choice Awards. [More]
Pluristem granted two key cell therapy patents in Japan

Pluristem granted two key cell therapy patents in Japan

Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing... [More]
Binding Site to collarborate in iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial

Binding Site to collarborate in iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial

Binding Site is proud to be a key collaborator with Prof Sigurdur Kristinsson of the University of Iceland in his pivotal MGUS screening study for the forthcoming iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial. [More]
Epigenomics receives FDA approval for Epi proColon®

Epigenomics receives FDA approval for Epi proColon®

Epigenomics AG, the German-American cancer molecular diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s lead product, Epi proColon®, the first and only FDA-approved blood-based colorectal cancer screening test. [More]
Oxford Gene Technology develops new FISH probes in ‘outstanding’ Innovate UK project

Oxford Gene Technology develops new FISH probes in ‘outstanding’ Innovate UK project

Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding’ award reserved for the top 10% of KTP projects. [More]
TyraTech launches award-winning head lice products, enters into French market

TyraTech launches award-winning head lice products, enters into French market

TyraTech, Inc., a life sciences technology company focused on nature-derived insect and parasite control products, announces a number of new initiatives including its expansion into the European market; the launch of a new product to complement the Vamousse range: Vamousse Lice Elimination for home cleaning; and further expansion of its distribution network in both the US and the UK. [More]
Advertisement
Advertisement